Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Epilepsy

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

The Next Frontier in Neurological Diagnostics and Therapeutics

Neurology

The Next Frontier in Neurological Diagnostics and Therapeutics

Dave Rosa

NeuroOne

PAO-05-24-CL-02May 30, 2024

Changing the Paradigm of Stem Cell Technology

Stem Cells

Changing the Paradigm of Stem Cell Technology

Sandy Solmon

Celavie Biosciences

PAP-Q4-20-CL-008December 09, 2020

Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy

Drug Development

Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy

Aquestive Therapeutics

PR-M12-18-NI-016December 06, 2018

New Analyses Evaluate Long-Term Convulsive Seizure Freedom Rates With Use Of Adjunctive FYCOMPA® (perampanel) CIII In Adult Patients Presented at Annual Meeting of the AES

Epilepsy

New Analyses Evaluate Long-Term Convulsive Seizure Freedom Rates With Use Of Adjunctive FYCOMPA® (perampanel) CIII In Adult Patients Presented at Annual Meeting of the AES

Eisai Inc.

PR-M12-18-NI-015December 05, 2018